These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2253220)

  • 1. Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin.
    Staroselsky AN; Fan D; O'Brian CA; Bucana CD; Gupta KP; Fidler IJ
    Cancer Res; 1990 Dec; 50(24):7775-80. PubMed ID: 2253220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic behavior of an adriamycin-resistant murine tumor.
    Giavazzi R; Miller L; Hart IR
    Cancer Res; 1983 Nov; 43(11):5081-6. PubMed ID: 6616446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes.
    Fan D; Bucana CD; O'Brian CA; Zwelling LA; Seid C; Fidler IJ
    Cancer Res; 1990 Jun; 50(12):3619-26. PubMed ID: 2340511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE; Fidler IJ
    J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line.
    Giavazzi R; Scholar E; Hart IR
    Cancer Res; 1983 May; 43(5):2216-22. PubMed ID: 6831444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.
    Raz A; Hanna N; Fidler IJ
    J Natl Cancer Inst; 1981 Jan; 66(1):183-9. PubMed ID: 6935459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
    J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells.
    Ganapathi R; Grabowski D; Schmidt H; Bell D; Melia M
    Cancer Res; 1987 Jul; 47(13):3464-8. PubMed ID: 2884031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells.
    Romerdahl CA; Donawho C; Fidler IJ; Kripke ML
    Cancer Res; 1988 Jul; 48(14):4007-10. PubMed ID: 3383194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system.
    Michowitz M; Dayan-Avidan G; Bar-Shira-Maymon B; Donin N; Leibovici J
    Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):551-60. PubMed ID: 8061572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
    Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
    Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro.
    O'Brian CA; Fan D; Ward NE; Dong Z; Iwamoto L; Gupta KP; Earnest LE; Fidler IJ
    Biochem Pharmacol; 1991 Mar; 41(5):797-806. PubMed ID: 1998534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.
    Shi Q; Huang S; Jiang W; Kutach LS; Ananthaswamy HN; Xie K
    Cancer Res; 1999 May; 59(9):2072-5. PubMed ID: 10232590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.